TARIS Biomedical Receives $32,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a384305-ba7a-46ff-99e5-f8262f42636e
Date
10/27/2015
Company Name
TARIS Biomedical
Mailing Address
113 Hartwell Avenue Lexington, MA 02421 USA
Company Description
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
Website
http://www.tarisbiomedical.com
Transaction Type
Venture Equity
Transaction Amount
$32,000,000
Transaction Round
Undisclosed
Proceeds Purposes
TARIS will use the proceeds from this current financing to advance an exciting new pipeline that targets a range of high unmet need bladder diseases, initially focusing on bladder cancer and overactive bladder segments.
M&A Terms
Venture Investor
Flagship Ventures
Venture Investor
Polaris Partners
Venture Investor
RA Capital